Search database
Filter
16
Text search: Medicines and Healthcare products Regulatory Agency (MHRA) UK
Featured
Language
Document type
No document type
7
Guidelines
4
Studies & Reports
3
Manuals
1
Fact sheets
1
Countries / Regions
Nigeria
1
Global
1
Authors & Publishers
National Institute for Health and Care Excellence (NICE)
2
World Health Organization WHO
2
BMA
1
European Public Health Alliance (EPHA), Changing Markets
1
Healthcare Improvement Scotland
1
KIT (Royal Tropical Institute) Development Policy & Practice/ Vrije Universiteit Amsterdam
1
Lubit, R.H. & Giardino, E.R.
1
Mauder, S.
1
Medicines and Healthcare products Regulatory Agency (MHRA) UK
1
Medscape
1
National Institute for Communicable Disease (NICE)
1
Royal College of Physicians, London
1
Royal Pharmaceutical Society, etal.
1
Sascha Marchang, Natasha Hurley
1
Scottish Intercollegiate Guideline Network
1
The fight against fake drugs by NAFDAC in Nigeria Olike Chinwendu
1
World Health Organisation (WHO)
1
World Health Organization
1
World Health Organization (WHO)
1
Publication Years
Category
Clinical Guidelines
3
Public Health
1
Countries
1
Key Resources
1
Toolboxes
Mental Health
5
COVID-19
3
Pharmacy
3
Disability
1
Rapid Response
1
HIV
1
AMR
1
NCDs
1
Clinical guideline | Published: 11 January 2012 | nice.org.uk/guidance/cg137

The fight against fake drugs by NAFDAC in Nigeria

The fight against fake drugs by NAFDAC in Nigeria Olike Chinwendu KIT (Royal Tropical Institute) Development Policy & Practice Vrije Universiteit Amsterdam (2008) CC
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration an ... more
Clinical Guideline
October 2018 HIV testing services

Diagnosis and management of epilepsy in adults

Healthcare Improvement Scotland Scottish Intercollegiate Guideline Network (2018) C1
SIGN 143. A national clinical guideline Published May 2015, Revised 2018

Type 2 diabetes in adults: management

National Institute for Communicable Disease (NICE) National Institute for Communicable Disease (NICE) (2022) CC2
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose le ... more
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by aut ... more
Posttraumatic stress disorder (PTSD) in children and adolescents occurs as a result of a child’s exposure to one or more traumatic events: actual or threatened death, serious injury, or sexual violence. The victim may experience the event, witness ... more
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal ... more
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants ... more
It is recommended that egg based quadrivalent vaccines for use in the 2019-2020 northern hemisphere influenza season contain the following: an A/Brisbane/02/2018 (H1N1)pdm09-like virus; an A(H3N2) virus to be announced on 21 March 2019*; a B/Colorado/06/2017-like virus (B/Victoria/ ... more

COVID-19 & Vaccination

Mauder, S. (2021) CC
Issue Brief no.8. January 18,2021 Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. B ... more